Research Progress and Challenges in Vaccine Development Against Classical Swine Fever Virus

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2021 Apr 3

PMID 33801868

Citations 14

Authors

Qiang Wei

Yunchao Liu

Gaiping Zhang

Affiliations

Soon will be listed here.

Abstract

Classical swine fever (CSF), caused by CSF virus (CSFV), is one of the most devastating viral epizootic diseases of swine in many countries. To control the disease, highly efficacious and safe live attenuated vaccines have been used for decades. However, the main drawback of these conventional vaccines is the lack of differentiability of infected from vaccinated animals (DIVA concept). Advances in biotechnology and our detailed knowledge of multiple basic science disciplines have facilitated the development of effective and safer DIVA vaccines to control CSF. To date, two types of DIVA vaccines have been developed commercially, including the subunit vaccines based on CSFV envelope glycoprotein E2 and chimeric pestivirus vaccines based on infectious cDNA clones of CSFV or bovine viral diarrhea virus (BVDV). Although inoculation of these vaccines successfully induces solid immunity against CSFV, none of them could ideally meet all demands regarding to safety, efficacy, DIVA potential, and marketability. Due to the limitations of the available choices, researchers are still striving towards the development of more advanced DIVA vaccines against CSF. This review summarizes the present status of candidate CSFV vaccines that have been developed. The strategies and approaches revealed here may also be helpful for the development of new-generation vaccines against other diseases.

Citing Articles

Molecular breeding of pigs in the genome editing era.

Chen J, Wang J, Zhao H, Tan X, Yan S, Zhang H Genet Sel Evol. 2025; 57(1):12.

PMID: 40065264 PMC: 11892312. DOI: 10.1186/s12711-025-00961-7.

Enhancement of immune responses to classical swine fever virus E2 in mice by fusion or mixture with the porcine IL-28B.

Yuan H, Jiao Y, Gao J, Wang T, Xia Y, Li K Appl Microbiol Biotechnol. 2025; 109(1):44.

PMID: 39945936 PMC: 11825588. DOI: 10.1007/s00253-024-13399-6.

Viral Live-Attenuated Vaccines (LAVs): Past and Future Directions.

Tang Y, Li Y, Cai X, Yin X Adv Sci (Weinh). 2024; 12(3):e2407241.

PMID: 39639853 PMC: 11744563. DOI: 10.1002/advs.202407241.

Development of a Ferritin-Based Nanoparticle Vaccine against Classical Swine Fever.

Song Y, Yuan Z, Ji J, Ruan Y, Li X, Wang L Vaccines (Basel). 2024; 12(8).

PMID: 39204071 PMC: 11360710. DOI: 10.3390/vaccines12080948.

Safety and DIVA Capability of Novel Live Attenuated Classical Swine Fever Marker Vaccine Candidates in Pregnant Sows.

Tong C, Mundt A, Meindl-Boehmer A, Haist V, Gallei A, Chen N Viruses. 2024; 16(7).

PMID: 39066207 PMC: 11281586. DOI: 10.3390/v16071043.

References

Kaden V, Lange E, Kuster H, Muller T, Lange B . An update on safety studies on the attenuated "RIEMSER Schweinepestoralvakzine" for vaccination of wild boar against classical swine fever. Vet Microbiol. 2009; 143(2-4):133-8. DOI: 10.1016/j.vetmic.2009.11.020. View

Becher P, Avalos Ramirez R, Orlich M, Cedillo Rosales S, Konig M, Schweizer M . Genetic and antigenic characterization of novel pestivirus genotypes: implications for classification. Virology. 2003; 311(1):96-104. DOI: 10.1016/s0042-6822(03)00192-2. View

Holinka L, Largo E, Gladue D, ODonnell V, Risatti G, Nieva J . Alteration of a Second Putative Fusion Peptide of Structural Glycoprotein E2 of Classical Swine Fever Virus Alters Virus Replication and Virulence in Swine. J Virol. 2016; 90(22):10299-10308. PMC: 5105664. DOI: 10.1128/JVI.01530-16. View

Edwards S, Fukusho A, Lefevre P, Lipowski A, Pejsak Z, Roehe P . Classical swine fever: the global situation. Vet Microbiol. 2000; 73(2-3):103-19. DOI: 10.1016/s0378-1135(00)00138-3. View

Olsen L, Chng T, Card J, Enquist L . Role of pseudorabies virus Us3 protein kinase during neuronal infection. J Virol. 2006; 80(13):6387-98. PMC: 1488934. DOI: 10.1128/JVI.00352-06. View

Munoz-Gonzalez S, Sordo Y, Perez-Simo M, Suarez M, Canturri A, Rodriguez M . Efficacy of E2 glycoprotein fused to porcine CD154 as a novel chimeric subunit vaccine to prevent classical swine fever virus vertical transmission in pregnant sows. Vet Microbiol. 2017; 205:110-116. DOI: 10.1016/j.vetmic.2017.05.003. View

Aynaud J, Lejolly J, Bibard C, Galicher C . [Studies of the properties of cold induced classical swine fever virus mutants. Application to vaccination]. Bull Off Int Epizoot. 1971; 75(9):654-9. View

Eble P, Geurts Y, Quak S, Moonen-Leusen H, Blome S, Hofmann M . Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Vet Microbiol. 2012; 162(2-4):437-446. DOI: 10.1016/j.vetmic.2012.10.030. View

Gao F, Jiang Y, Li G, Zhou Y, Yu L, Li L . Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV. Vaccine. 2018; 36(23):3269-3277. DOI: 10.1016/j.vaccine.2018.04.079. View

10.

Terpstra C, Kroese A . Potency control of modified live viral vaccines for veterinary use. Vaccine. 1996; 14(6):570-5. DOI: 10.1016/0264-410x(96)83467-0. View

11.

Pose A, Gomez J, Sanchez A, Redondo A, Rodriguez E, Montesino Segui R . Subunit influenza vaccine candidate based on CD154 fused to HAH5 increases the antibody titers and cellular immune response in chickens. Vet Microbiol. 2011; 152(3-4):328-37. DOI: 10.1016/j.vetmic.2011.05.033. View

12.

Xia S, Xiang G, Lei J, Du M, Wang Y, Zhou M . Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain. Vet Microbiol. 2016; 196:50-54. DOI: 10.1016/j.vetmic.2016.10.001. View

13.

Sanchez Ramos O, Pose A, Gomez-Puerta S, Gomez J, Redondo A, Aguila Benites J . Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens. Comp Immunol Microbiol Infect Dis. 2010; 34(3):259-65. DOI: 10.1016/j.cimid.2010.12.001. View

14.

Kitajima M, Hamazaki H, Miyano-Kurosaki N, Takaku H . Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem Biophys Res Commun. 2006; 343(2):378-84. DOI: 10.1016/j.bbrc.2006.02.167. View

15.

Marconi G, Albertini E, Barone P, De Marchis F, Lico C, Marusic C . In planta production of two peptides of the Classical Swine Fever Virus (CSFV) E2 glycoprotein fused to the coat protein of potato virus X. BMC Biotechnol. 2006; 6:29. PMC: 1534020. DOI: 10.1186/1472-6750-6-29. View

16.

Konig M, Lengsfeld T, Pauly T, Stark R, Thiel H . Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol. 1995; 69(10):6479-86. PMC: 189549. DOI: 10.1128/JVI.69.10.6479-6486.1995. View

17.

Park Y, Lee S, Kang H, Park M, Min K, Kim N . A classical swine fever virus E2 fusion protein produced in plants elicits a neutralizing humoral immune response in mice and pigs. Biotechnol Lett. 2020; 42(7):1247-1261. PMC: 7223222. DOI: 10.1007/s10529-020-02892-3. View

18.

Wang X, Jiang P, Li Y, Jiang W, Dong X . Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2. Vet Microbiol. 2007; 121(3-4):215-24. DOI: 10.1016/j.vetmic.2006.11.027. View

19.

Li Y, Jin Q, Ding P, Zhou W, Chai Y, Li X . Gold nanoparticles enhance immune responses in mice against recombinant classical swine fever virus E2 protein. Biotechnol Lett. 2020; 42(7):1169-1180. DOI: 10.1007/s10529-020-02853-w. View

20.

Hulst M, Westra D, Wensvoort G, Moormann R . Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol. 1993; 67(9):5435-42. PMC: 237945. DOI: 10.1128/JVI.67.9.5435-5442.1993. View